Your session is about to expire
← Back to Search
Combinatory Rehabilitation for Traumatic Brain Injury (CRUSH-IT Trial)
Phase 1
Recruiting
Led By Nancy D Chiaravalloti, PhD
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 to 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to provide evidence of combined KF-mSMT and AET for rehabilitating NLMI in TBI, to help those with TBI-related NLMI return to work, manage everyday life and maintain quality of life.
Who is the study for?
This trial is for adults aged 18-65 with moderate-to-severe traumatic brain injury (TBI) diagnosed at least a year ago. Participants should be physically inactive, right-handed, have memory impairments, and able to follow directions. They must not have severe mental illness, regular steroid or benzodiazepine use, significant vision impairment, unsafe conditions for MRI scans or high exercise risks.
What is being tested?
The study tests the Kessler Foundation modified Story Memory Technique (KF-mSMT) combined with either aerobic exercise training (AET) or stretching exercises. It's a double-blind randomized controlled trial aiming to improve new learning and memory in TBI patients by comparing these two methods over a 12-week program.
What are the potential side effects?
Potential side effects are not explicitly listed but may include typical reactions to physical activity such as muscle soreness or fatigue from aerobic or stretching exercises. Since it's an exercise-based intervention, risks might also involve strain injuries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from 0 to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 to 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in California Verbal Learning Test-3 Performance
Secondary study objectives
Change in Everyday Memory Simulations Performance
Change in hippocampal activation
Change in hippocampal resting-state functional connectivity
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: KF-mSMT Plus Aerobic Exercise TrainingExperimental Treatment1 Intervention
Participants will undergo 12 weeks of supervised aerobic cycling exercise training. During the last 8 weeks of cycling exercise, participants will also undergo treatment with the Kessler Foundation modified Story Memory Technique as an approach for cognitive rehabilitation.
Group II: KF-mSMT Plus Stretching Exercise TrainingActive Control1 Intervention
Participants will undergo 12 weeks of supervised stretching and toning exercise training. During the last 8 weeks of stretching exercise, participants will also undergo treatment with the Kessler Foundation modified Story Memory Technique as an approach for cognitive rehabilitation.
Find a Location
Who is running the clinical trial?
Kessler FoundationLead Sponsor
182 Previous Clinical Trials
11,033 Total Patients Enrolled
Nancy D Chiaravalloti, PhDPrincipal InvestigatorKessler Foundation
4 Previous Clinical Trials
261 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can follow directions well, as shown by my TICS-M score.I was diagnosed with a severe brain injury over a year ago.I regularly take steroids and benzodiazepines for medication effects.I am between 18 and 65 years old.
Research Study Groups:
This trial has the following groups:- Group 1: KF-mSMT Plus Aerobic Exercise Training
- Group 2: KF-mSMT Plus Stretching Exercise Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger